Upregulated PDK4 expression is a sensitive marker of increased fatty acid oxidation.


Journal

Mitochondrion
ISSN: 1872-8278
Titre abrégé: Mitochondrion
Pays: Netherlands
ID NLM: 100968751

Informations de publication

Date de publication:
11 2019
Historique:
received: 12 04 2019
revised: 01 07 2019
accepted: 24 07 2019
pubmed: 29 7 2019
medline: 7 5 2020
entrez: 29 7 2019
Statut: ppublish

Résumé

Fatty acid oxidation is a central fueling pathway for mitochondrial ATP production. Regulation occurs through multiple nutrient- and energy-sensitive molecular mechanisms. We explored if upregulated mRNA expression of the mitochondrial enzyme pyruvate dehydrogenase kinase 4 (PDK4) may be used as a surrogate marker of increased mitochondrial fatty acid oxidation, by indicating an overall shift from glucose to fatty acids as the preferred oxidation fuel. The association between fatty acid oxidation and PDK4 expression was studied in different contexts of metabolic adaption. In rats treated with the modified fatty acid tetradecylthioacetic acid (TTA), Pdk4 was upregulated simultaneously with fatty acid oxidation genes in liver and heart, whereas muscle and white adipose tissue remained unaffected. In MDA-MB-231 cells, fatty acid oxidation increased nearly three-fold upon peroxisome proliferator-activated receptor α (PPARα, PPARA) overexpression, and four-fold upon TTA-treatment. PDK4 expression was highly increased under these conditions. Further, overexpression of PDK4 caused increased fatty acid oxidation in these cells. Pharmacological activators of PPARα and AMPK had minor effects, while the mTOR inhibitor rapamycin potentiated the effect of TTA. There were minor changes in mitochondrial respiration, glycolytic function, and mitochondrial biogenesis under conditions of increased fatty acid oxidation. TTA was found to act as a mild uncoupler, which is likely to contribute to the metabolic effects. Repeated experiments with HeLa cells supported these findings. In summary, PDK4 upregulation implies an overarching metabolic shift towards increased utilization of fatty acids as energy fuel, and thus constitutes a sensitive marker of enhanced fatty acid oxidation.

Identifiants

pubmed: 31351920
pii: S1567-7249(19)30085-6
doi: 10.1016/j.mito.2019.07.009
pii:
doi:

Substances chimiques

Biomarkers 0
Fatty Acids 0
Mitochondrial Proteins 0
PDK4 protein, human 0
Pdk4 protein, rat 0
Pyruvate Dehydrogenase Acetyl-Transferring Kinase 0
Sulfides 0
1-(carboxymethylthio)tetradecane 7ZU5I25S2O

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

97-110

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Auteurs

Ina Katrine Nitschke Pettersen (IKN)

Department of Biomedicine, University of Bergen, Norway.

Deusdedit Tusubira (D)

Department of Biomedicine, University of Bergen, Norway.

Hanan Ashrafi (H)

Department of Biomedicine, University of Bergen, Norway.

Sissel Elisabeth Dyrstad (SE)

Department of Biomedicine, University of Bergen, Norway.

Lena Hansen (L)

Department of Biomedicine, University of Bergen, Norway; Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway.

Xiao-Zheng Liu (XZ)

Department of Biomedicine, University of Bergen, Norway.

Linn Iren Hodneland Nilsson (LIH)

Department of Biomedicine, University of Bergen, Norway.

Nils Gunnar Løvsletten (NG)

Department of Pharmacy, University of Oslo, Norway.

Kjetil Berge (K)

Skretting AS, Stavanger, Norway.

Hege Wergedahl (H)

Department of Sport, Food and Natural Sciences, Western Norway University of Applied Sciences, Bergen, Norway.

Bodil Bjørndal (B)

Department of Clinical Science, University of Bergen, Norway.

Øystein Fluge (Ø)

Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway.

Ove Bruland (O)

Department of Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway.

Arild Christian Rustan (AC)

Department of Pharmacy, University of Oslo, Norway.

Nils Halberg (N)

Department of Biomedicine, University of Bergen, Norway.

Gro Vatne Røsland (GV)

Department of Biomedicine, University of Bergen, Norway; Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway.

Rolf Kristian Berge (RK)

Department of Clinical Science, University of Bergen, Norway; Department of Heart Disease, Haukeland University Hospital, Bergen, Norway.

Karl Johan Tronstad (KJ)

Department of Biomedicine, University of Bergen, Norway. Electronic address: karl.tronstad@uib.no.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH